1 enrolling by invitation. .
Follow HRI-MAIL-NIT: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Non-Invasive Testing in Major Liver-Related Outcomes Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD | Enrolling by invitation | HRI-MAIL-NIT | 1689 | 2025-10-25 | 2026-03-27 |
United States (1)